Point72 Asset Management
FATE icon

Point72 Asset Management’s Fate Therapeutics FATE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,584,300
Closed -$11.6M 1368
2024
Q1
$11.6M Sell
1,584,300
-1,904,863
-55% -$14M 0.03% 556
2023
Q4
$13M Buy
3,489,163
+3,415,762
+4,654% +$12.8M 0.03% 509
2023
Q3
$156K Buy
73,401
+63,265
+624% +$134K ﹤0.01% 1185
2023
Q2
$48.2K Buy
+10,136
New +$48.2K ﹤0.01% 1089
2020
Q4
Sell
-151,564
Closed -$6.06M 921
2020
Q3
$6.06M Sell
151,564
-175,272
-54% -$7.01M 0.03% 485
2020
Q2
$11.2M Buy
+326,836
New +$11.2M 0.07% 293
2020
Q1
Sell
-782,783
Closed -$15.3M 837
2019
Q4
$15.3M Sell
782,783
-397,306
-34% -$7.78M 0.08% 289
2019
Q3
$18.3M Buy
1,180,089
+586,589
+99% +$9.11M 0.11% 226
2019
Q2
$12M Buy
593,500
+93,500
+19% +$1.9M 0.06% 304
2019
Q1
$8.79M Buy
+500,000
New +$8.79M 0.04% 375